Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00248170 | Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer(FACE) | completed | Phase 3 | 4,172 | Novartis PharmaceuticalsINDUSTRY | 20 | Apr 19, 2016 | clinicaltrials |
| NCT02620371 | Efficacy of Ketamine Added to Local Anesthetic in Modified Pectoral Block for Management of Postoperative Pain | completed | Phase 3 | 60 | Assiut UniversityOTHER | 1 | Apr 19, 2016 |
| clinicaltrials |
| NCT00000611 | Women's Health Initiative (WHI) | completed | Phase 3 | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Apr 15, 2016 | clinicaltrials |
| NCT00320385 | Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer | completed | Phase 3 | 296 | GlaxoSmithKlineINDUSTRY | 13 | Feb 26, 2016 | clinicaltrials |
| NCT01530607 | Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer | completed | Phase 3 | 416 | King Faisal Specialist Hospital & Research CenterOTHER | 0 | Feb 25, 2016 | clinicaltrials |
| NCT00544232 | Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) | completed | Phase 3 | 720 | GBG Forschungs GmbHOTHER | 0 | Feb 15, 2016 | clinicaltrials |
| NCT01426880 | Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer(GeparSixto) | completed | Phase 2 / Phase 3 | 595 | GBG Forschungs GmbHOTHER | 1 | Feb 15, 2016 | clinicaltrials |
| NCT01250379 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA) | completed | Phase 3 | 494 | Hoffmann-La RocheINDUSTRY | 13 | Feb 11, 2016 | clinicaltrials |
| NCT00567554 | Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer(GeparQuinto) | completed | Phase 3 | 2,600 | GBG Forschungs GmbHOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT01204437 | Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast(ICE-II) | completed | Phase 2 / Phase 3 | 400 | GBG Forschungs GmbHOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT00333775 | A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer | completed | Phase 3 | 736 | Hoffmann-La RocheINDUSTRY | 24 | Jan 27, 2016 | clinicaltrials |
| NCT01112254 | Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer(IRCIS) | completed | Phase 3 | 360 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT00540800 | BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer(BREAST-10) | completed | Phase 3 | 139 | National Cancer Institute, NaplesOTHER | 1 | Jan 14, 2016 | clinicaltrials |
| NCT02058615 | Feasibility Testing and Evaluation of an Online Toolkit for Male Spouses of Women With Breast Cancer | completed | Phase 3 | 57 | University of AlbertaOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00202059 | Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer | completed | Phase 3 | 72 | HealthPartners InstituteOTHER | 1 | Dec 16, 2015 | clinicaltrials |
| NCT02613026 | Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer | completed | Phase 3 | 104 | 307 Hospital of PLAOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT00902330 | Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer | completed | Phase 3 | 161 | Virginia Commonwealth UniversityOTHER | 0 | Nov 23, 2015 | clinicaltrials |
| NCT00005975 | S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer | completed | Phase 3 | 288 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 18, 2015 | clinicaltrials |
| NCT00003162 | Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer | completed | Phase 3 | 949 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT00036270 | Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane(TEAM) | completed | Phase 3 | 9,779 | PfizerINDUSTRY | 1 | Oct 28, 2015 | clinicaltrials |
| NCT00003906 | Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women | completed | Phase 3 | 19,747 | NSABP Foundation IncNETWORK | 3 | Oct 6, 2015 | clinicaltrials |
| NCT01433614 | Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer(TEX) | completed | Phase 3 | 304 | Thomas HatschekOTHER | 1 | Sep 17, 2015 | clinicaltrials |
| NCT01688479 | Trial Comparing Calendula Officinalis With Aqueous Cream "Essex" to Treat Skin Reactions From Radiotherapy of Breast Cancer | completed | Phase 3 | 420 | Karolinska University HospitalOTHER | 1 | Sep 17, 2015 | clinicaltrials |
| NCT02548338 | Argon Plasma Coagulation Scalpel on Surgical Treatment of Breast Cancer | completed | Phase 2 / Phase 3 | 60 | Federal University of São PauloOTHER | 0 | Sep 14, 2015 | clinicaltrials |
| NCT00375505 | The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss | completed | Phase 3 | 70 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 7, 2015 | clinicaltrials |
| NCT00528567 | BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer | completed | Phase 3 | 2,591 | Hoffmann-La RocheINDUSTRY | 40 | Sep 4, 2015 | clinicaltrials |
| NCT00391092 | A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 16 | Aug 28, 2015 | clinicaltrials |
| NCT02525159 | Effectiveness of DIM Supplements to Increase 2-OHE1/16 Ratio(EDIMI216OHE1) | completed | Phase 3 | 60 | Instituto Nacional de Perinatologia Isidro Espinosa de los ReyesOTHER_GOV | 0 | Aug 17, 2015 | clinicaltrials |
| NCT01281904 | Acupressure for Persistent Cancer Related Fatigue(AcuCrft) | completed | Phase 2 / Phase 3 | 288 | University of MichiganOTHER | 1 | Aug 6, 2015 | clinicaltrials |
| NCT00044291 | Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | completed | Phase 3 | 865 | Intarcia TherapeuticsINDUSTRY | 4 | Jul 31, 2015 | clinicaltrials |
| NCT00990977 | Mindfulness and Cancer Mamma - Clinical Trial MBSR Among Women Operated for Breast Cancer(MICA) | completed | Phase 2 / Phase 3 | 336 | Danish Cancer SocietyOTHER | 1 | Jun 30, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT02450058 | Adjuvant FEC Versus EP in Breast Cancer (MIG5)(MIG5) | completed | Phase 3 | 1,055 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT00424606 | Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients | completed | Phase 3 | 658 | Hellenic Oncology Research GroupOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00075270 | Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer | completed | Phase 3 | 580 | GlaxoSmithKlineINDUSTRY | 25 | May 6, 2015 | clinicaltrials |
| NCT01519700 | Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim(PIONEER) | completed | Phase 3 | 218 | SandozINDUSTRY | 6 | May 6, 2015 | clinicaltrials |
| NCT00201851 | Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer | completed | Phase 3 | 740 | International Breast Cancer Research FoundationOTHER | 3 | Apr 29, 2015 | clinicaltrials |
| NCT01300351 | Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women | completed | Phase 3 | 249 | AstraZenecaINDUSTRY | 1 | Apr 24, 2015 | clinicaltrials |
| NCT02408107 | A Home-based Physical Activity Intervention in Breast Cancer Survivors(PHAB) | completed | Phase 3 | 80 | Dudley Group NHS Foundation TrustOTHER | 0 | Apr 14, 2015 | clinicaltrials |
| NCT00542542 | Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery | completed | Phase 3 | 89 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 13, 2015 | clinicaltrials |
| NCT01287624 | Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)(TNBC) | completed | Phase 3 | 240 | Fudan UniversityOTHER | 1 | Mar 23, 2015 | clinicaltrials |
| NCT00593697 | The Synergism Or Long Duration (SOLD) Study(SOLD) | completed | Phase 3 | 2,168 | Finnish Breast Cancer GroupOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT00512993 | Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy(NATAN) | completed | Phase 3 | 654 | GBG Forschungs GmbHOTHER | 2 | Mar 5, 2015 | clinicaltrials |
| NCT00615602 | Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer | completed | Phase 3 | 489 | Hellenic Oncology Research GroupOTHER | 1 | Mar 4, 2015 | clinicaltrials |
| NCT00929240 | A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer | completed | Phase 3 | 287 | Hoffmann-La RocheINDUSTRY | 11 | Mar 3, 2015 | clinicaltrials |
| NCT00065325 | The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer(EFECT) | completed | Phase 3 | 694 | AstraZenecaINDUSTRY | 15 | Feb 24, 2015 | clinicaltrials |
| NCT02314806 | Gentamicin Versus Clindamycin Versus Normal Saline Lavage in Axilla | completed | Phase 3 | 51 | Hospital General Universitario ElcheOTHER | 0 | Dec 11, 2014 | clinicaltrials |
| NCT00983684 | Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer(TARGIT) | completed | Phase 3 | 3,451 | University College, LondonOTHER | 1 | Dec 5, 2014 | clinicaltrials |
| NCT00459771 | Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity | completed | Phase 3 | 210 | The Netherlands Cancer InstituteOTHER | 1 | Dec 2, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Apr 19, 2016source: clinicaltrials